Company Update: Allergan Inc (NYSE:AGN) – Allergan to Acquire Oculeve Dry Eye Disease Development Programs

[PR Newswire] – DUBLIN and SOUTH SAN FRANCISCO, Calif., July 6, 2015 /PRNewswire/ — Allergan plc (AGN), a leading global pharmaceutical company, and Oculeve, a development-stage medical device company focused on developing novel . . . → Read More: Company Update: Allergan Inc (NYSE:AGN) – Allergan to Acquire Oculeve Dry Eye Disease Development Programs Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi – sources Stock Update: Allergan Inc (NYSE:AGN) – FDA Approves Allergan’s NATRELLE INSPIRA™ Round Gel-Filled Breast Implants Company Update (NYSE:UNH): UnitedHealth CEO predicts growth across the company in 2015